| Autor: |
Strahan AG; Department of Dermatology, Massachusetts General Hospital, Boston, MA, USA.; Mercer University School of Medicine, Savannah, GA, USA., Davies OMT; Department of Dermatology, Massachusetts General Hospital, Boston, MA, USA.; Harvard Medical School Combined Dermatology Program, Boston, MA, USA., Fernández LT; Department of Dermatology, Hospital Universitario José E. Gonzalez, Monterrey, México., Gaylord IWI; Department of Dermatology, Hopital du Cinquantenaire de Kisangani, Kisangani, DR Congo., Mekonnen YG; Department of Dermatology, College of Health and Medical Science, Haramaya University, Harar, Ethiopia., Grijsen ML; Oxford University Clinical Research Unit Indonesia, Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia.; Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Ollague JE; Hospital General Guasmo Sur, Guayaquil, Ecuador., Sabushimike D; Hopital Militaire de Kamenge, Bujumbura, Burundi., Polo Silveira L; Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY, USA., Maurer T; Department of Dermatology, Indiana University School of Medicine, Indianapolis, IN, USA., Dodiuk-Gad RP; Department of Dermatology, Emek Medical Center, Afula, Israel.; Division of Dermatology, Department of Medicine, University of Toronto, Toronto, ON, Canada.; Department of Dermatology, Bruce Rappaport Faculty of Medicine, Technion Institute of Technology, Haifa, Israel., Singal A; Department of Dermatology, University College of Medical Sciences & G.T.B. Hospital, Dilshad Garden, Delhi, India., Lim HW; Department of Dermatology, Henry Ford Health, Detroit, MI, USA.; International League of Dermatological Societies, London, UK., Bhose A; International League of Dermatological Societies, London, UK., Lubov JE; Department of Dermatology, Massachusetts General Hospital, Boston, MA, USA.; Wright State University Boonshoft School of Medicine, Dayton, OH, USA., Jain S; Louisiana State University Health Sciences Center New Orleans, New Orleans, LA, USA., Zehtab M; Department of Dermatology, Massachusetts General Hospital, Boston, MA, USA., Allison T; CeraVe - L'Oréal Group, New York, NY, USA., Guerin M; CeraVe - L'Oréal Group, New York, NY, USA., Enbiale W; Department of Dermatology, College of Health Sciences and Medicine, Bahir Dar University, Bahir Dar, Ethiopia.; Department of Dermatology, Amsterdam Institute for Infection and Immunity (AII), Academic Medical Centre, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands., Rehmus W; Division of Dermatology, BC Children's Hospital, University of British Columbia, Vancouver, BC, Canada., Wanat KA; Department of Dermatology and Pathology, Medical College of Wisconsin, Milwaukee, WI, USA., Fuller LC; London Bridge Hospital, London, UK.; International Foundation for Dermatology, London, UK., Bailey E; Department of Dermatology, Stanford University School of Medicine, Redwood City, CA, USA., Freeman EE; Department of Dermatology, Massachusetts General Hospital, Boston, MA, USA.; International Foundation for Dermatology, London, UK.; Medical Practice Evaluation Foundation, Massachusetts General Hospital, Boston, MA, USA. |
| Abstrakt: |
Competing Interests: Conflicts of interest L.C.F. is the Chair of the International Foundation of Dermatology (IFD). E.E.F. is the Vice Chair of IFD. H.W.L. is the President of the International League of Dermatological Societies (ILDS). These positions are unpaid. A.B. is the CEO of ILDS. J.E.O. is the President of the Ecuadorian Society of Dermatology. R.P.D.-G. is a consultant to the following companies: Sanofi, AbbVie, Pfizer, Janssen, Novartis, La Roche-Posay, Dexcel, Eli Lilly and Devintec Pharma. E.E.F. is a consultant for L’Oréal and CeraVe. H.W.L. has served as investigator for Incyte, La Roche-Posay, Pfizer and the Patient-Centered Outcomes Research Institute (PCORI), as consultant for ISDIN, Beiersdorf, Ferndale, L’Oreal and Eli Lilly, and as a speaker for La Roche-Posay, Cantabria Labs, Pierre Fabre, NAOS, Uriage and Pfizer. W.R. has served as an investigator for UCB, consultant for AbbVie, Pfizer, LEO, Miravo, and speaker for CeraVe, Novartis and Pfizer. |
